Login to Your Account

Other News To Note

Monday, March 25, 2013
• pSivida Corp., of Watertown, Mass., said licensee Alimera Sciences Inc., of Atlanta, disclosed plans to resubmit a new drug application for Iluvien (fluocinolone acetonide intravitreal implant) in diabetic macular edema (DME) by the end of March.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription